Evidence map›Paper›PMID 30363947›Full record

ArticleOxidative medicine and cellular longevity2018

Treatment of NASH with Antioxidant Therapy: Beneficial Effect of Red Cabbage on Type 2 Diabetic Rats.

Stéphanie Dal, Remmelt Van der Werf, Catherine Walter, William Bietiger, Elodie Seyfritz, Carole Mura, Claude Peronet, Julie Legrandois, Dalal Werner, Said Ennahar and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Stéphanie DalUniversité de Strasbourg, Centre Européen d'Etude du Diabète, DIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, F-67000 Strasbourg, France.
Remmelt Van der WerfUniversité de Strasbourg, Centre Européen d'Etude du Diabète, DIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, F-67000 Strasbourg, France.
Catherine WalterUniversité de Strasbourg, Centre Européen d'Etude du Diabète, DIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, F-67000 Strasbourg, France.
William BietigerUniversité de Strasbourg, Centre Européen d'Etude du Diabète, DIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, F-67000 Strasbourg, France.
Elodie SeyfritzUniversité de Strasbourg, Centre Européen d'Etude du Diabète, DIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, F-67000 Strasbourg, France.
Carole MuraUniversité de Strasbourg, Centre Européen d'Etude du Diabète, DIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, F-67000 Strasbourg, France.ORCID 0000-0003-0305-711X
Claude PeronetUniversité de Strasbourg, Centre Européen d'Etude du Diabète, DIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, F-67000 Strasbourg, France.
Julie LegrandoisAérial, Illkirch, France.
Dalal WernerAérial, Illkirch, France.
Said EnnaharEquipe de Chimie Analytique des Molécules BioActives, IPHC-LC4, UMR 7178, Faculté de Pharmacie, Ilkirch, France.
Fabien DigelInterprofession des Fruits et Légumes d'Alsace (IFLA), Sainte Croix en Plaine, France.
Maillard-Pedracini ElisaUniversité de Strasbourg, Centre Européen d'Etude du Diabète, DIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, F-67000 Strasbourg, France.ORCID 0000-0001-7134-7499
Michel PingetUniversité de Strasbourg, Centre Européen d'Etude du Diabète, DIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, F-67000 Strasbourg, France.
Nathalie JeandidierStructure d'Endocrinologie, Diabète, Nutrition et Addictologie, Pôle NUDE, Hôpitaux Universitaires de Strasbourg (HUS), 67000 Strasbourg, France.
Eric MarchioniEquipe de Chimie Analytique des Molécules BioActives, IPHC-LC4, UMR 7178, Faculté de Pharmacie, Ilkirch, France.
Séverine SigristUniversité de Strasbourg, Centre Européen d'Etude du Diabète, DIATHEC EA 7294, Fédération de Médecine Translationnelle de Strasbourg, F-67000 Strasbourg, France.ORCID 0000-0002-5766-2596
Université de Strasbourg · FRInstitut Pluridisciplinaire Hubert Curien · FRHôpitaux Universitaires de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsOxidative stress (OS) plays a major role in type 2 diabetes and its vascular and hepatic complications, and novel therapeutic approaches include natural antioxidants. Our previous chemical and biological studies demonstrated the antioxidant activities of red cabbage (RC), and here, we aimed to determine the

resultsThis vegetable, associated with lifestyle measurement, was shown to decrease OS and increase vascular endothelial NO synthase expression, ensuring vascular homeostasis. In the liver, RC consumption decreased OS by inhibiting p22phox expression and Nrf2 degradation and increasing catalase activity. It inhibited the activation of SREBP (1c, 2), ChREBP, NF- CONCLUSION/INNOVATION: RC consumption led to metabolic profile improvement, together with hepatic function improvements. Although lifestyle changes are not sufficient to prevent diabetic complications, enrichment with RC avoids progression hepatic complications. This antioxidant strategy using RC does not only able to increase antioxidant defense, such as classical antioxidant, but also able to assure a metabolic and energetic balance to reverse complications. Whereas traditional medical therapy failed to reverse NASH in diabetic patients, consumption of RC should be a natural therapy to treat it.

Indexed as

AnimalsAntioxidantsBiological AvailabilityBiomarkersBlood VesselsBody WeightBrassicaDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Diet, High-FatEndothelium, VascularFastingFructoseGlucoseInflammationLipid MetabolismAntioxidantsBiomarkersFructoseGlucoseNitric OxideNitric Oxide Synthase Type III

Identifiers

PMID30363947
PMCPMC6186311
OpenAlexW2893613755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.